{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T10:54:41Z","timestamp":1782644081169,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GPO-A-00-04-00019-00"],"award-info":[{"award-number":["GPO-A-00-04-00019-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI098645"],"award-info":[{"award-number":["AI098645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51 OD011104-52"],"award-info":[{"award-number":["P51 OD011104-52"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13346-017-0389-0","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T13:42:07Z","timestamp":1497015727000},"page":"840-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques"],"prefix":"10.1007","volume":"7","author":[{"given":"Nina","family":"Derby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meropi","family":"Aravantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta R.","family":"Ugaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Wesenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Kizima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixa","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mizenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Levendosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Seidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agegnehu","family":"Gettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Grasperge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Piatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Fern\u00e1ndez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Zydowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Robbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"issue":"1","key":"389_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.contraception.2015.09.002","volume":"93","author":"E Schelar","year":"2016","unstructured":"Schelar E, Polis CB, Essam T, Looker KJ, Bruni L, Chrisman CJ, et al. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Contraception. 2016;93(1):32\u201343. doi:\n                    10.1016\/j.contraception.2015.09.002\n                    \n                  .","journal-title":"Contraception"},{"key":"389_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2014.12.005","volume":"92","author":"JA Fernandez-Romero","year":"2015","unstructured":"Fernandez-Romero JA, Teleshova N, Zydowsky TM, Robbiani M. Preclinical assessments of vaginal microbicide candidate safety and efficacy. Adv Drug Deliv Rev. 2015;92:27\u201338. doi:\n                    10.1016\/j.addr.2014.12.005\n                    \n                  .","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"389_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","volume":"23","author":"JA Fernandez-Romero","year":"2015","unstructured":"Fernandez-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, et al. Multipurpose prevention technologies: the future of HIV and STI protection. Trends Microbiol. 2015;23(7):429\u201336. doi:\n                    10.1016\/j.tim.2015.02.006\n                    \n                  .","journal-title":"Trends Microbiol"},{"issue":"6","key":"389_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318. doi:\n                    10.1056\/NEJMoa1402269\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"389_CR5","unstructured":"Rees H, Delany-Moretlwe S, Lombard C, Baron D, Panchia R, Myer L et al. FACTS 001 Phase III trial of pericoital tenofovir 1% gel for HIV prevention in women. CROI 2015; Seattle, WA2015."},{"issue":"3","key":"389_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/infdis\/jiv333","volume":"213","author":"JY Dai","year":"2016","unstructured":"Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje ZM, et al. Pharmacological measures of treatment adherence and risk of HIV infection in the VOICE study. J Infect Dis. 2016;213(3):335\u201342. doi:\n                    10.1093\/infdis\/jiv333\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"389_CR7","doi-asserted-by":"publisher","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016; doi:\n                    10.1056\/NEJMoa1506110\n                    \n                  .","DOI":"10.1056\/NEJMoa1506110"},{"issue":"1","key":"389_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/eri.12.155","volume":"11","author":"N Derby","year":"2013","unstructured":"Derby N, Zydowsky T, Robbiani M. In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward? Expert Rev Anti-Infect Ther. 2013;11(1):5\u20138. doi:\n                    10.1586\/eri.12.155\n                    \n                  .","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"3","key":"389_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.antiviral.2013.06.021","volume":"99","author":"DR Friend","year":"2013","unstructured":"Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antivir Res. 2013;99(3):391\u2013400. doi:\n                    10.1016\/j.antiviral.2013.06.021\n                    \n                  .","journal-title":"Antivir Res"},{"issue":"4","key":"389_CR10","doi-asserted-by":"publisher","first-page":"e94547","DOI":"10.1371\/journal.pone.0094547","volume":"9","author":"L Kizima","year":"2014","unstructured":"Kizima L, Rodriguez A, Kenney J, Derby N, Mizenina O, Menon R, et al. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS One. 2014;9(4):e94547. doi:\n                    10.1371\/journal.pone.0094547\n                    \n                  .","journal-title":"PLoS One"},{"issue":"47","key":"389_CR11","doi-asserted-by":"publisher","first-page":"40433","DOI":"10.1074\/jbc.M111.289850","volume":"286","author":"KJ Fenstermacher","year":"2011","unstructured":"Fenstermacher KJ, DeStefano JJ. Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity. J Biol Chem. 2011;286(47):40433\u201342. doi:\n                    10.1074\/jbc.M111.289850\n                    \n                  .","journal-title":"J Biol Chem"},{"issue":"1","key":"389_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1128\/AAC.05461-11","volume":"56","author":"JA Fernandez-Romero","year":"2012","unstructured":"Fernandez-Romero JA, Abraham CJ, Rodriguez A, Kizima L, Jean-Pierre N, Menon R, et al. Zinc acetate\/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob Agents Chemother. 2012;56(1):358\u201368. doi:\n                    10.1128\/AAC.05461-11\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"389_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/aid.2013.0165","volume":"30","author":"M Hsu","year":"2014","unstructured":"Hsu M, Aravantinou M, Menon R, Seidor S, Goldman D, Kenney J, et al. A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge. AIDS Res Hum Retrovir. 2014;30(2):174\u201383. doi:\n                    10.1089\/AID.2013.0165\n                    \n                  .","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"389_CR14","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1128\/AAC.00796-13","volume":"57","author":"J Kenney","year":"2013","unstructured":"Kenney J, Rodriguez A, Kizima L, Seidor S, Menon R, Jean-Pierre N, et al. A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo. Antimicrob Agents Chemother. 2013;57(8):4001\u20139. doi:\n                    10.1128\/AAC.00796-13\n                    \n                  .","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"389_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nm1598","volume":"13","author":"JN Roberts","year":"2007","unstructured":"Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med. 2007;13(7):857\u201361. doi:\n                    10.1038\/nm1598\n                    \n                  .","journal-title":"Nat Med"},{"issue":"9","key":"389_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jnci\/djr061","volume":"103","author":"JN Roberts","year":"2011","unstructured":"Roberts JN, Kines RC, Katki HA, Lowy DR, Schiller JT. Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J Natl Cancer Inst. 2011;103(9):737\u201343. doi:\n                    10.1093\/jnci\/djr061\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"key":"389_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.antiviral.2014.05.018","volume":"108","author":"A Rodriguez","year":"2014","unstructured":"Rodriguez A, Kleinbeck K, Mizenina O, Kizima L, Levendosky K, Jean-Pierre N, et al. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antivir Res. 2014;108:88\u201393. doi:\n                    10.1016\/j.antiviral.2014.05.018\n                    \n                  .","journal-title":"Antivir Res"},{"issue":"8","key":"389_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3851\/IMP1890","volume":"16","author":"D Marais","year":"2011","unstructured":"Marais D, Gawarecki D, Allan B, Ahmed K, Altini L, Cassim N, et al. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir Ther. 2011;16(8):1219\u201326. doi:\n                    10.3851\/IMP1890\n                    \n                  .","journal-title":"Antivir Ther"},{"issue":"1","key":"389_CR19","doi-asserted-by":"publisher","first-page":"e15835","DOI":"10.1371\/journal.pone.0015835","volume":"6","author":"J Kenney","year":"2011","unstructured":"Kenney J, Aravantinou M, Singer R, Hsu M, Rodriguez A, Kizima L, et al. An antiretroviral\/zinc combination gel provides 24\u00a0hours of complete protection against vaginal SHIV infection in macaques. PLoS One. 2011;6(1):e15835. doi:\n                    10.1371\/journal.pone.0015835\n                    \n                  .","journal-title":"PLoS One"},{"issue":"11","key":"389_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/aid.2014.0207","volume":"30","author":"J Kenney","year":"2014","unstructured":"Kenney J, Derby N, Aravantinou M, Kleinbeck K, Frank I, Gettie A, et al. Short communication: a repeated simian human immunodeficiency virus reverse transcriptase\/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicides. AIDS Res Hum Retrovir. 2014;30(11):1117\u201324. doi:\n                    10.1089\/aid.2014.0207\n                    \n                  .","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"389_CR21","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1089\/aid.2012.0087","volume":"28","author":"J Kenney","year":"2012","unstructured":"Kenney J, Singer R, Derby N, Aravantinou M, Abraham CJ, Menon R, et al. A single dose of a MIV-150\/zinc acetate gel provides 24\u00a0h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8\u201324\u00a0h after gel use. AIDS Res Hum Retrovir. 2012;28(11):1476\u201384. doi:\n                    10.1089\/AID.2012.0087\n                    \n                  .","journal-title":"AIDS Res Hum Retrovir"},{"key":"389_CR22","unstructured":"WHO. List of essential medicines. 2013. \n                    http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/18th_EML_Final_web_8Jul13.pdf\n                    \n                  ."},{"key":"389_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2015.06.018","volume":"213","author":"SR Ugaonkar","year":"2015","unstructured":"Ugaonkar SR, Wesenberg A, Wilk J, Seidor S, Mizenina O, Kizima L, et al. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. J Control Release. 2015;213:57\u201368. doi:\n                    10.1016\/j.jconrel.2015.06.018\n                    \n                  .","journal-title":"J Control Release"},{"issue":"9","key":"389_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/aid.2010.0252","volume":"27","author":"O Begay","year":"2011","unstructured":"Begay O, Jean-Pierre N, Abraham CJ, Chudolij A, Seidor S, Rodriguez A, et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retrovir. 2011;27(9):1019\u201324. doi:\n                    10.1089\/AID.2010.0252\n                    \n                  .","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"389_CR25","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.73.11.8966-8974.1999","volume":"73","author":"A Trkola","year":"1999","unstructured":"Trkola A, Matthews J, Gordon C, Ketas T, Moore JP. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol. 1999;73(11):8966\u201374.","journal-title":"J Virol"},{"key":"389_CR26","first-page":"375","volume-title":"Diagnostic procedures for viral, rickettsial, and chlamydial infections","author":"R Ashley","year":"1995","unstructured":"Ashley R. Herpes simplex viruses. In: Schmidt N, Emmons R, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections. Washington, DC: American Public Health Association; 1995. p. 375\u201395."},{"key":"389_CR27","unstructured":"Animal Welfare Act and Regulation Code of Federal Regulations. Beltsville, MD: Department of Agriculture; 2001."},{"key":"389_CR28","unstructured":"Guide for the Care and Use of Laboratory Animals. The National Academies Press; 2011."},{"issue":"2","key":"389_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ygyno.2016.09.003","volume":"143","author":"AP Novetsky","year":"2016","unstructured":"Novetsky AP, Keller MJ, Gradissimo A, Chen Z, Morgan SL, Xue X, et al. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel. Gynecol Oncol. 2016;143(2):313\u20138. doi:\n                    10.1016\/j.ygyno.2016.09.003\n                    \n                  .","journal-title":"Gynecol Oncol"},{"issue":"150","key":"389_CR30","doi-asserted-by":"publisher","first-page":"150ra23","DOI":"10.1126\/scitranslmed.3003936","volume":"4","author":"R Singer","year":"2012","unstructured":"Singer R, Mawson P, Derby N, Rodriguez A, Kizima L, Menon R, et al. An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci Transl Med. 2012;4(150):150ra23. doi:\n                    10.1126\/scitranslmed.3003936\n                    \n                  .","journal-title":"Sci Transl Med"},{"issue":"4","key":"389_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.contraception.2008.01.003","volume":"77","author":"JT Jensen","year":"2008","unstructured":"Jensen JT, Zelinski MB, Stanley JE, Fanton JW, Stouffer RL. The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques. Contraception. 2008;77(4):303\u20137. doi:\n                    10.1016\/j.contraception.2008.01.003\n                    \n                  .","journal-title":"Contraception"},{"issue":"2","key":"389_CR32","doi-asserted-by":"publisher","first-page":"e89300","DOI":"10.1371\/journal.pone.0089300","volume":"9","author":"M Hsu","year":"2014","unstructured":"Hsu M, Keele BF, Aravantinou M, Krawczyk N, Seidor S, Abraham CJ, et al. Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques. PLoS One. 2014;9(2):e89300. doi:\n                    10.1371\/journal.pone.0089300\n                    \n                  .","journal-title":"PLoS One"},{"issue":"5","key":"389_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0010-7824(95)00210-2","volume":"52","author":"T Luukkainen","year":"1995","unstructured":"Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception. 1995;52(5):269\u201376.","journal-title":"Contraception"},{"issue":"3","key":"389_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0010-7824(80)90003-7","volume":"21","author":"CG Nilsson","year":"1980","unstructured":"Nilsson CG, Lahteenmaki P, Luukkainen T. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. Contraception. 1980;21(3):225\u201333.","journal-title":"Contraception"},{"issue":"5","key":"389_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0010-7824(85)90016-2","volume":"32","author":"BL Xiao","year":"1985","unstructured":"Xiao BL, Zhang XL, Feng DD. Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel. Contraception. 1985;32(5):455\u201371.","journal-title":"Contraception"},{"key":"389_CR36","unstructured":"Stanford University HIV Drug resistance database. 2016."},{"issue":"4","key":"389_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1095\/biolreprod29.4.841","volume":"29","author":"ML Walker","year":"1983","unstructured":"Walker ML, Gordon TP, Wilson ME. Menstrual cycle characteristics of seasonally breeding rhesus monkeys. Biol Reprod. 1983;29(4):841\u20138.","journal-title":"Biol Reprod"},{"issue":"4","key":"389_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/aji.12201","volume":"71","author":"SV Hadzic","year":"2014","unstructured":"Hadzic SV, Wang X, Dufour J, Doyle L, Marx PA, Lackner AA, et al. Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle. Am J Reprod Immunol. 2014;71(4):322\u20139. doi:\n                    10.1111\/aji.12201\n                    \n                  .","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"389_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1210\/er.2009-0018","volume":"31","author":"Z Hel","year":"2010","unstructured":"Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 2010;31(1):79\u201397. doi:\n                    10.1210\/er.2009-0018\n                    \n                  .","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"389_CR40","first-page":"S125","volume":"14","author":"S Hild-Petito","year":"1998","unstructured":"Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retrovir. 1998;14(Suppl 1):S125\u201330.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"10","key":"389_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nm1096-1084","volume":"2","author":"PA Marx","year":"1996","unstructured":"Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996;2(10):1084\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"389_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/aji.12246","volume":"71","author":"JM McNicholl","year":"2014","unstructured":"McNicholl JM, Henning TC, Vishwanathan SA, Kersh EN. Non-human primate models of hormonal contraception and HIV. Am J Reprod Immunol. 2014;71(6):513\u201322. doi:\n                    10.1111\/aji.12246\n                    \n                  .","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"389_CR43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/aji.12422","volume":"74","author":"WA Nichols","year":"2015","unstructured":"Nichols WA, Birke L, Dufour J, Loganantharaj N, Bagby GJ, Nelson S, et al. Characterization of the genital microenvironment of female rhesus macaques prior to and after SIV infection. Am J Reprod Immunol. 2015;74(6):508\u201322. doi:\n                    10.1111\/aji.12422\n                    \n                  .","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"389_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/315776","volume":"182","author":"SM Smith","year":"2000","unstructured":"Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis. 2000;182(3):708\u201315. doi:\n                    10.1086\/315776\n                    \n                  .","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"389_CR45","first-page":"S119","volume":"14","author":"DL Sodora","year":"1998","unstructured":"Sodora DL, Gettie A, Miller CJ, Marx PA. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retrovir. 1998;14(Suppl 1):S119\u201323.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"389_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jac\/dks415","volume":"68","author":"SM Fetherston","year":"2013","unstructured":"Fetherston SM, Geer L, Veazey RS, Goldman L, Murphy DJ, Ketas TJ, et al. Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220. J Antimicrob Chemother. 2013;68(2):394\u2013403. doi:\n                    10.1093\/jac\/dks415\n                    \n                  .","journal-title":"J Antimicrob Chemother"},{"issue":"40","key":"389_CR47","doi-asserted-by":"publisher","first-page":"16145","DOI":"10.1073\/pnas.1311355110","volume":"110","author":"JM Smith","year":"2013","unstructured":"Smith JM, Rastogi R, Teller RS, Srinivasan P, Mesquita PM, Nagaraja U, et al. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc Natl Acad Sci U S A. 2013;110(40):16145\u201350. doi:\n                    10.1073\/pnas.1311355110\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"389_CR48","doi-asserted-by":"publisher","first-page":"e0157061","DOI":"10.1371\/journal.pone.0157061","volume":"11","author":"P Srinivasan","year":"2016","unstructured":"Srinivasan P, Moss JA, Gunawardana M, Churchman SA, Yang F, Dinh CT, et al. Topical delivery of tenofovir disoproxil fumarate and emtricitabine from pod-intravaginal rings protects macaques from multiple SHIV exposures. PLoS One. 2016;11(6):e0157061. doi:\n                    10.1371\/journal.pone.0157061\n                    \n                  .","journal-title":"PLoS One"},{"issue":"6","key":"389_CR49","doi-asserted-by":"publisher","first-page":"e1005720","DOI":"10.1371\/journal.ppat.1005720","volume":"12","author":"G Arrode-Bruses","year":"2016","unstructured":"Arrode-Bruses G, Goode D, Kleinbeck K, Wilk J, Frank I, Byrareddy S, et al. A small molecule, which competes with MAdCAM-1, activates integrin alpha4beta7 and fails to prevent mucosal transmission of SHIV-SF162P3. PLoS Pathog. 2016;12(6):e1005720. doi:\n                    10.1371\/journal.ppat.1005720\n                    \n                  .","journal-title":"PLoS Pathog"},{"issue":"15","key":"389_CR50","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/QAD.0b013e32834a1d94","volume":"25","author":"C Cheng-Mayer","year":"2011","unstructured":"Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, et al. Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS. 2011;25(15):1833\u201341. doi:\n                    10.1097\/QAD.0b013e32834a1d94\n                    \n                  .","journal-title":"AIDS"},{"issue":"12","key":"389_CR51","doi-asserted-by":"publisher","first-page":"e1004567","DOI":"10.1371\/journal.ppat.1004567","volume":"10","author":"D Goode","year":"2014","unstructured":"Goode D, Truong R, Villegas G, Calenda G, Guerra-Perez N, Piatak M, et al. HSV-2-driven increase in the expression of alpha4beta7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection. PLoS Pathog. 2014;10(12):e1004567. doi:\n                    10.1371\/journal.ppat.1004567\n                    \n                  .","journal-title":"PLoS Pathog"},{"issue":"5","key":"389_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijantimicag.2013.01.004","volume":"41","author":"J Weiss","year":"2013","unstructured":"Weiss J, Haefeli WE. Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro. Int J Antimicrob Agents. 2013;41(5):484\u20137. doi:\n                    10.1016\/j.ijantimicag.2013.01.004\n                    \n                  .","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"389_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jfprhc-2013-100844","volume":"41","author":"LB Haddad","year":"2015","unstructured":"Haddad LB, Philpott-Jones S, Schonfeld T. Contraception and prevention of HIV transmission: a potential conflict of public health principles. J Fam Plann Reprod Health Care. 2015;41(1):20\u20133. doi:\n                    10.1136\/jfprhc-2013-100844\n                    \n                  .","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"389_CR54","doi-asserted-by":"publisher","first-page":"e1001778","DOI":"10.1371\/journal.pmed.1001778","volume":"12","author":"CS Morrison","year":"2015","unstructured":"Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12(1):e1001778. doi:\n                    10.1371\/journal.pmed.1001778\n                    \n                  .","journal-title":"PLoS Med"},{"issue":"2","key":"389_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(14)71052-7","volume":"15","author":"LJ Ralph","year":"2015","unstructured":"Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women\u2019s risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis. 2015;15(2):181\u20139. doi:\n                    10.1016\/S1473-3099(14)71052-7\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"389_CR56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.contraception.2014.08.008","volume":"90","author":"CL Westhoff","year":"2014","unstructured":"Westhoff CL, Winikoff B. DMPA and HIV: do we need a trial? Contraception. 2014;90(4):353. doi:\n                    10.1016\/j.contraception.2014.08.008\n                    \n                  .","journal-title":"Contraception"},{"issue":"7","key":"389_CR57","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/1933719114565035","volume":"22","author":"GA Goldfien","year":"2015","unstructured":"Goldfien GA, Barragan F, Chen J, Takeda M, Irwin JC, Perry J, et al. Progestin-containing contraceptives alter expression of host defense-related genes of the endometrium and cervix. Reprod Sci. 2015;22(7):814\u201328. doi:\n                    10.1177\/1933719114565035\n                    \n                  .","journal-title":"Reprod Sci"},{"key":"389_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0065-2776(08)00003-5","volume":"97","author":"T Hirano","year":"2008","unstructured":"Hirano T, Murakami M, Fukada T, Nishida K, Yamasaki S, Suzuki T. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol. 2008;97:149\u201376. doi:\n                    10.1016\/S0065-2776(08)00003-5\n                    \n                  .","journal-title":"Adv Immunol"},{"issue":"1","key":"389_CR59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/rej.2007.0613","volume":"11","author":"L Kahmann","year":"2008","unstructured":"Kahmann L, Uciechowski P, Warmuth S, Plumakers B, Gressner AM, Malavolta M, et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res. 2008;11(1):227\u201337. doi:\n                    10.1089\/rej.2007.0613\n                    \n                  .","journal-title":"Rejuvenation Res"},{"issue":"1\u20133","key":"389_CR60","first-page":"21","volume":"121","author":"E Mocchegiani","year":"2000","unstructured":"Mocchegiani E, Giacconi R, Muzzioli M, Cipriano C. Zinc, infections and immunosenescence. Mech Ageing Dev. 2000;121(1\u20133):21\u201335.","journal-title":"Mech Ageing Dev"},{"issue":"1\u20133","key":"389_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0047-6374(00)00145-7","volume":"117","author":"E Mocchegiani","year":"2000","unstructured":"Mocchegiani E, Giacconi R, Muzzioli M, Gasparini N, Provinciali L, Spazzafumo L, et al. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6. Mech Ageing Dev. 2000;117(1\u20133):79\u201391.","journal-title":"Mech Ageing Dev"},{"issue":"5S Suppl","key":"389_CR62","doi-asserted-by":"crossref","first-page":"1424S","DOI":"10.1093\/jn\/130.5.1424S","volume":"130","author":"E Mocchegiani","year":"2000","unstructured":"Mocchegiani E, Muzzioli M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr. 2000;130(5S Suppl):1424S\u201331S.","journal-title":"J Nutr"},{"issue":"2","key":"389_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1010095930854","volume":"1","author":"E Mocchegiani","year":"2000","unstructured":"Mocchegiani E, Muzzioli M, Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology. 2000;1(2):133\u201343.","journal-title":"Biogerontology"},{"issue":"5S Suppl","key":"389_CR64","doi-asserted-by":"crossref","first-page":"1407S","DOI":"10.1093\/jn\/130.5.1407S","volume":"130","author":"L Rink","year":"2000","unstructured":"Rink L, Kirchner H. Zinc-altered immune function and cytokine production. J Nutr. 2000;130(5S Suppl):1407S\u201311S.","journal-title":"J Nutr"},{"issue":"2 Suppl","key":"389_CR65","doi-asserted-by":"crossref","first-page":"447S","DOI":"10.1093\/ajcn\/68.2.447S","volume":"68","author":"AH Shankar","year":"1998","unstructured":"Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2 Suppl):447S\u201363S.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"389_CR66","doi-asserted-by":"publisher","first-page":"e8060","DOI":"10.1371\/journal.pone.0008060","volume":"4","author":"F Crostarosa","year":"2009","unstructured":"Crostarosa F, Aravantinou M, Akpogheneta OJ, Jasny E, Shaw A, Kenney J, et al. A macaque model to study vaginal HSV-2\/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy. PLoS One. 2009;4(11):e8060. doi:\n                    10.1371\/journal.pone.0008060\n                    \n                  .","journal-title":"PLoS One"},{"issue":"3","key":"389_CR67","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1128\/JVI.06077-11","volume":"86","author":"S Gianella","year":"2012","unstructured":"Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, et al. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol. 2012;86(3):1307\u201315. doi:\n                    10.1128\/JVI.06077-11\n                    \n                  .","journal-title":"J Virol"},{"issue":"8","key":"389_CR68","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1086\/591913","volume":"198","author":"KE Mark","year":"2008","unstructured":"Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang ML, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis. 2008;198(8):1141\u20139. doi:\n                    10.1086\/591913\n                    \n                  .","journal-title":"J Infect Dis"},{"issue":"14","key":"389_CR69","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/jama.2011.420","volume":"305","author":"E Tronstein","year":"2011","unstructured":"Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305(14):1441\u20139. doi:\n                    10.1001\/jama.2011.420\n                    \n                  .","journal-title":"JAMA"},{"issue":"5","key":"389_CR70","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","volume":"35","author":"L Corey","year":"2004","unstructured":"Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435\u201345.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"389_CR71","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","volume":"2","author":"CB Buck","year":"2006","unstructured":"Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006;2(7):e69. doi:\n                    10.1371\/journal.ppat.0020069\n                    \n                  .","journal-title":"PLoS Pathog"},{"issue":"1","key":"389_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000000402","volume":"68","author":"JM Smith","year":"2015","unstructured":"Smith JM, Srinivasan P, Teller RS, Lo Y, Dinh CT, Kiser PF, et al. Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. J Acquir Immune Defic Syndr. 2015;68(1):1\u20135. doi:\n                    10.1097\/QAI.0000000000000402\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"389_CR73","doi-asserted-by":"publisher","first-page":"e97767","DOI":"10.1371\/journal.pone.0097767","volume":"9","author":"D Goode","year":"2014","unstructured":"Goode D, Aravantinou M, Jarl S, Truong R, Derby N, Guerra-Perez N, et al. Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission. PLoS One. 2014;9(5):e97767. doi:\n                    10.1371\/journal.pone.0097767\n                    \n                  .","journal-title":"PLoS One"},{"issue":"6","key":"389_CR74","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.contraception.2010.06.006","volume":"82","author":"RA Lewis","year":"2010","unstructured":"Lewis RA, Taylor D, Natavio MF, Melamed A, Felix J, Mishell D Jr. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception. 2010;82(6):491\u20136. doi:\n                    10.1016\/j.contraception.2010.06.006\n                    \n                  .","journal-title":"Contraception"},{"issue":"6","key":"389_CR75","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2007.10.014","volume":"131","author":"J Munch","year":"2007","unstructured":"Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell. 2007;131(6):1059\u201371. doi:\n                    10.1016\/j.cell.2007.10.014\n                    \n                  .","journal-title":"Cell"},{"issue":"3","key":"389_CR76","doi-asserted-by":"publisher","first-page":"e59777","DOI":"10.1371\/journal.pone.0059777","volume":"8","author":"S Tan","year":"2013","unstructured":"Tan S, Lu L, Li L, Liu J, Oksov Y, Lu H, et al. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection. PLoS One. 2013;8(3):e59777. doi:\n                    10.1371\/journal.pone.0059777\n                    \n                  .","journal-title":"PLoS One"},{"issue":"9","key":"389_CR77","doi-asserted-by":"publisher","first-page":"e108109","DOI":"10.1371\/journal.pone.0108109","volume":"9","author":"P Barnable","year":"2014","unstructured":"Barnable P, Calenda G, Ouattara L, Gettie A, Blanchard J, Jean-Pierre N, et al. A MIV-150\/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants. PLoS One. 2014;9(9):e108109. doi:\n                    10.1371\/journal.pone.0108109\n                    \n                  .","journal-title":"PLoS One"},{"issue":"11","key":"389_CR78","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1128\/JVI.00012-13","volume":"87","author":"B Nixon","year":"2013","unstructured":"Nixon B, Stefanidou M, Mesquita PM, Fakioglu E, Segarra T, Rohan L, et al. Griffithsin protects mice from genital herpes by preventing cell-to-cell spread. J Virol. 2013;87(11):6257\u201369. doi:\n                    10.1128\/JVI.00012-13\n                    \n                  .","journal-title":"J Virol"},{"issue":"3","key":"389_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jac\/dki464","volume":"57","author":"OJ D\u2019Cruz","year":"2006","unstructured":"D\u2019Cruz OJ, Uckun FM. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J Antimicrob Chemother. 2006;57(3):411\u201323. doi:\n                    10.1093\/jac\/dki464\n                    \n                  .","journal-title":"J Antimicrob Chemother"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-017-0389-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0389-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0389-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:32:56Z","timestamp":1589740376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-017-0389-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0389-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]},"assertion":[{"value":"9 June 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the experiments published in this manuscript comply with the current laws of the country in which they were performed. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Nina Derby, author Shweta R. Ugaonkar, author Jessica Kenney, author Meropi Aravantinou, author Asa Wesenberg, author Jolanta Wilk, author Larisa Kizima, author Aixa Rodriguez, author Shimin Zhang, author Olga Mizenina, author Keith Levendosky, author Michael L. Cooney, author Samantha Seidor, author Agegnehu Gettie, author Brooke Grasperge, author James Blanchard, author Jeffrey D. Lifson, author Jos\u00e9 Fern\u00e1ndez-Romero, author Thomas M. Zydowsky, and author Melissa Robbiani declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}